Literature DB >> 21768183

Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility.

Marion Ingeborg Boldingh1, Unn Ljøstad, Ase Mygland, Per Monstad.   

Abstract

BACKGROUND: Vestibular migraine (VM) has gained recognition as a distinct clinical entity in recent years. The pathophysiology is unclear. Vestibular evoked myogenic potential (VEMP) is a validated method to test the vestibulocollic reflex and peripheral vestibular hypersensitivity to noise. The aim of our study was to evaluate the vestibular function and sensitivity in a series of VM patients in comparison to ordinary migraine (M) patient and healthy controls.
METHODS: Thirty-seven patients diagnosed with VM according to the Neuhauser criteria, 32 migraineurs, and 30 healthy persons underwent VEMP testing (response and sound intensity threshold) and a motion sickness susceptibility questionnaire.
RESULTS: We found absence of unilateral or bilateral VEMP response at 90  dB normal hearing level (nHL) in 44% of the VM patients, in 25% of the migraineurs, as compared to in 3% of the healthy controls (p  =  0.001). The sound intensity threshold and latencies were similar in all the groups. Migraineurs (VM > M) reported more motion sickness than healthy controls (p  =   0.006).
CONCLUSION: The results indicate more pathology in the VEMP circuitry in migraineurs than in healthy controls. We did not find support for peripheral vestibular hypersensitivity in terms of lower VEMP threshold among VM patients, but they are more sensitive for motion triggers than other migraineurs.

Entities:  

Mesh:

Year:  2011        PMID: 21768183     DOI: 10.1177/0333102411409074

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  23 in total

1.  Can vestibular-evoked myogenic potentials help differentiate Ménière disease from vestibular migraine?

Authors:  M Geraldine Zuniga; Kristen L Janky; Michael C Schubert; John P Carey
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-20       Impact factor: 3.497

Review 2.  Vestibular Migraine in Children and Adolescents.

Authors:  Thyra Langhagen; Mirjam N Landgraf; Doreen Huppert; Florian Heinen; Klaus Jahn
Journal:  Curr Pain Headache Rep       Date:  2016-12

3.  Motion Sickness Susceptibility and Baseline Vestibular and Ocular-Motor Performance in Adolescent Athletes.

Authors:  R J Elbin; Anthony P Kontos; Alicia Sufrinko; Mallory McElroy; Katie Stephenson-Brown; Samantha Mohler; Nathan R D'Amico; Michael W Collins
Journal:  J Athl Train       Date:  2019-08-27       Impact factor: 2.860

Review 4.  Vestibular Migraine.

Authors:  Shin C Beh
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-31       Impact factor: 6.030

5.  Vestibular Evoked Myogenic Potentials in a Female Population with Migraine.

Authors:  Sertac Yetiser; Meltem Hale Gok; Yasar Kutukcu; Dilay Ince
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-12-13

6.  Motion sensitivity and caloric responsiveness in vestibular migraine and Meniere's disease.

Authors:  Jeffrey D Sharon; Timothy E Hullar
Journal:  Laryngoscope       Date:  2014-01-15       Impact factor: 3.325

Review 7.  Vestibular-evoked myogenic potentials in central vestibular disorders.

Authors:  Sun-Young Oh; Hyo-Jeong Kim; Ji-Soo Kim
Journal:  J Neurol       Date:  2015-08-05       Impact factor: 4.849

8.  Evolution of migraine vertigo in overlapping syndrome with Ménière's disease: prognostic role of instrumental examination.

Authors:  Francesco Dispenza; Angelo Immordino; Roberta Priola; Pietro Salvago; Calogero Montalbano; Francesco Martines
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

9.  The Relationship Between Vestibular Migraine and Motion Sickness Susceptibility.

Authors:  Mehdi Abouzari; Dillon Cheung; Tiffany Pham; Khodayar Goshtasbi; Brooke Sarna; Sarah Tajran; Sammy Sahyouni; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2020-09       Impact factor: 2.619

10.  Vestibular migraine in children and adolescents: clinical findings and laboratory tests.

Authors:  Thyra Langhagen; Nicole Lehrer; Ingo Borggraefe; Florian Heinen; Klaus Jahn
Journal:  Front Neurol       Date:  2015-01-26       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.